share_log

Safe Supply Streaming Corp. (SPLY) Announces Landmark USA Expansion of Portfolio Company, Safety Strips Tech Corp., in Partnership With Greenlane Holdings, Inc.

Safe Supply Streaming Corp. (SPLY) Announces Landmark USA Expansion of Portfolio Company, Safety Strips Tech Corp., in Partnership With Greenlane Holdings, Inc.

安全供应流媒体公司(SPLY)宣布,其投资组合公司Safety Strips Tech Corp.与Greenlane Holdings,Inc.合作,在美国实现了具有里程碑意义的扩张。
newsfile ·  08/13 08:00

Greenlane's significant retail doors boost Safety Strips' market reach. Greenlane's U.S. sales team accelerates Safety Strips' market entry. Partnership with Greenlane drives immediate revenue for Safety Strips accretively. Partnership supports Safety Strips' sustained growth and innovation.

Greenlane的重要零售门扩大了安全条的市场覆盖范围。Greenlane的美国销售团队加快了安全带的市场准入。与Greenlane的合作增加了安全带的即时收入。合作伙伴关系支持Safety Strips的持续增长和创新。

Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or "the Company") is thrilled to announce a major milestone for its portfolio company, Safety Strips Tech Corp. ("Safety Strips"). Safety Strips has entered into a landmark expansion agreement with Greenlane Holdings, Inc. (NASDAQ: GNLN), a leading distributor of vape, smoke, and cannabis accessories to distribute Safety Strips' harm reduction test strips for fentanyl, drink spike and xylazine to thousands of retailers across the United States.

安大略省多伦多--(Newsfile Corp.,2024年8月13日)——安全供应流媒体有限公司(CSE:SPLY)(FSE:QM4)(场外交易代码:SSPLF)(“安全供应” 或 “公司”)很高兴地宣布其投资组合公司Safety Strips Tech Corp.(“Safety Strips”)(“安全带”)的一个重要里程碑。Safety Strips已与领先的电子烟、烟雾和大麻配件分销商Greenlane Holdings, Inc.(纳斯达克股票代码:GNLN)签订了一项具有里程碑意义的扩张协议,向美国数千家零售商分发Safety Strips的芬太尼、饮料刺和二甲苯嗪减害试纸。

This strategic partnership positions Safety Strips for significant growth and underscores its commitment to providing cutting-edge medical testing solutions to address large-scale problems. To many professionals, teenagers and students are being negatively impacted by toxic substances that have varying degree of harmful implications.

这种战略合作伙伴关系使Safety Strips实现了显著增长,并凸显了其致力于提供尖端医学测试解决方案以解决大规模问题的承诺。对许多专业人士来说,青少年和学生正受到有毒物质的负面影响,这些物质具有不同程度的有害影响。

Greenlane's expansive distribution network and industry expertise will enable Safety Strips to rapidly increase its market presence, delivering innovative test strips for toxic substances to a broad consumer base. With the USA's growing demand for reliable and accessible safety solutions, this partnership is poised to drive immediate revenue growth and further solidify Safety Strips' position as a leader in the sector.

Greenlane庞大的分销网络和行业专业知识将使Safety Strips能够迅速增加其市场占有率,为广泛的消费者群提供创新的有毒物质试纸。随着美国对可靠且易于使用的安全解决方案的需求不断增长,这种伙伴关系有望推动即时收入增长,并进一步巩固Safety Strips作为该行业领导者的地位。

Geoff Benic, CEO of Safety Strips Tech Corp., commented, "We are focused on immediate revenue, and having a sophisticated partner like Greenlane, with its large distribution network, is highly accretive to Safety Strips. Our portfolio of test strips for toxic substances is just the beginning-we will be announcing our wellness division shortly, further expanding our product offerings. The strategic partnership with Greenlane aligns perfectly with our vision of revolutionizing the medical testing industry and creating long-term value for our shareholders."

Safety Strips Tech Corp. 首席执行官杰夫·贝尼克评论说:“我们专注于即时收入,拥有像Greenlane这样拥有庞大分销网络的成熟合作伙伴将极大地促进安全带的发展。我们的有毒物质试纸产品组合仅仅是开端——我们将很快宣布我们的健康部门,进一步扩大我们的产品范围。与Greenlane的战略合作伙伴关系完全符合我们彻底改变医学检验行业并为股东创造长期价值的愿景。”

Highlights of the transaction include:

该交易的亮点包括:

  • Strategic Partnership with Greenlane: Aligns Safety Strips with Greenlane, one of the largest and most reputable distributors in the U.S., serving over 11,000 retailers. This partnership significantly enhances market reach and positions Safety Strips for rapid expansion in a critical market segment.
  • Access to Extensive Retail Network: Greenlane's retail network, which spans over 7,000 retail doors nationwide, ensures broad and immediate product distribution, potentially reaching millions of consumers across the U.S., thereby increasing brand visibility and sales velocity.
  • Boots on the Ground Sales Force: Greenlane provides an experienced sales team across the U.S., enabling a hands-on, localized approach to product distribution. This direct engagement with retailers supports a faster product rollout and drives immediate revenue growth, with the potential to scale rapidly.
  • Strategic Revenue Pathway: The partnership offers a clear and scalable path to revenue, leveraging Greenlane's established distribution channels, which generated over $130 million in revenue in 2023. This collaboration is expected to translate into significant sales for Safety Strips products in a short period.
  • Leveraging Greenlane's Expertise: Utilizes Greenlane's robust marketing, sales, and operational capabilities, including their expertise in logistics and customer support, to maximize brand exposure, consumer adoption, and market penetration. This strategic alliance enhances operational efficiency and market responsiveness.
  • Introduction of Wellness Strips: In addition to fentanyl and xylazine detection, Safety Strips is expanding its product portfolio with Wellness Strips, which provide at-home testing for blood sugar levels, pH levels, and other key health indicators. This diversification into wellness products addresses a growing consumer demand for proactive health management tools.
  • Integration of Advanced Technology: Safety Strips plans to integrate its products into a comprehensive health and safety ecosystem, utilizing advanced AI-powered technology for real-time data analysis and personalized recommendations. This technological integration will enhance user experience, providing actionable insights and fostering long-term consumer engagement.
  • Addressing a National Health Crisis: Safety Strips' high-sensitivity detection products meet an urgent need in the ongoing opioid crisis, offering a reliable, low-cost solution for detecting dangerous adulterants like fentanyl and xylazine. With over 100,000 opioid- related deaths in the U.S. in 2023 alone, this product is poised to make a significant impact on public health.
  • Potential for Long-Term Growth: The partnership is structured to support sustained growth, with future potential for expanded product lines, including advanced wellness testing strips and digital health solutions. This positions Safety Strips at the forefront of innovation in public health and safety, with long-term value creation for investors.
  • 与 Greenlane 的战略合作伙伴关系:Safety Strips 与 Greenlane 保持一致,Greenlane 是美国最大和最负盛名的分销商之一,为 11,000 多家零售商提供服务。这种合作关系极大地扩大了市场覆盖范围,使安全条能够在关键细分市场快速扩张。
  • 进入广泛的零售网络:Greenlane的零售网络遍及全国7,000多个零售门户,可确保广泛和即时的产品分销,有可能覆盖美国数百万消费者,从而提高品牌知名度和销售速度。
  • Boots on the Ground 销售队伍:Greenlane 在美国各地提供一支经验丰富的销售团队,为产品分销提供动手实践的本地化方法。这种与零售商的直接合作支持了更快的产品推出并推动了收入的即时增长,并有可能迅速扩大规模。
  • 战略收入途径:该合作伙伴关系利用Greenlane已建立的分销渠道提供了一条清晰且可扩展的收入途径,该渠道在2023年创造了超过1.3亿美元的收入。预计这种合作将在短时间内转化为安全条产品的大量销售。
  • 利用 Greenlane 的专业知识:利用 Greenlane 强大的营销、销售和运营能力,包括他们在物流和客户支持方面的专业知识,最大限度地提高品牌知名度、消费者采用率和市场渗透率。这种战略联盟提高了运营效率和市场响应能力。
  • 健康试纸简介:除了芬太尼和赛拉嗪检测外,Safety Strips还通过Wellness Strips扩展其产品组合,该产品可对血糖水平、pH值和其他关键健康指标进行居家检测。这种向健康产品的多样化满足了消费者对主动健康管理工具不断增长的需求。
  • 先进技术的整合:Safety Strips计划将其产品整合到一个全面的健康和安全生态系统中,利用先进的人工智能技术进行实时数据分析和个性化推荐。这种技术整合将增强用户体验,提供切实可行的见解并促进长期的消费者参与度。
  • 应对国家健康危机:Safety Strips的高灵敏度检测产品满足了持续的阿片类药物危机的迫切需求,为检测芬太尼和赛拉嗪等危险掺杂物提供了可靠、低成本的解决方案。仅在2023年,美国就有超过10万例与阿片类药物相关的死亡,该产品有望对公共卫生产生重大影响。
  • 长期增长潜力:该合作伙伴关系旨在支持持续增长,未来有可能扩大产品线,包括先进的健康试纸和数字健康解决方案。这使Safety Strips处于公共健康和安全创新的最前沿,为投资者创造长期价值。

Bill Panagiotakopoulos, CEO of Safe Supply Streaming Corp., added, "This is another significant step towards our full pivot out of the streaming model and towards our medical testing strategy powered by AI."

Safe Supply Streaming Corp. 首席执行官比尔·帕纳焦塔科普洛斯补充说:“这是我们朝着全面退出流媒体模式和迈向由人工智能驱动的医学测试战略迈出的又一重要一步。”

The harm reduction test strips market in the United States is experiencing rapid growth, driven by increasing awareness and demand for tools that can combat the opioid crisis. With over 100,000 opioid-related deaths in the U.S. in 2023, the need for accessible and reliable testing solutions has never been greater. In a significant policy shift, President Joe Biden recently moved to reschedule fentanyl test strips, recognizing their vital role in preventing drug overdoses. This regulatory change presents an opportune moment to bring these test strips to retailers across the country, positioning them within the expanding medical testing category. As more consumers and healthcare providers seek effective ways to detect dangerous substances, Safety Strips is poised to meet this critical need with innovative, high-sensitivity products designed to save lives.

在对抗阿片类药物危机的工具的认识和需求不断提高的推动下,美国的减害试纸市场正在快速增长。2023年,美国有超过10万例与阿片类药物相关的死亡,对可获得和可靠的测试解决方案的需求空前强烈。在一项重大政策转变中,乔·拜登总统最近开始重新安排芬太尼试纸的时间,承认芬太尼试纸在防止药物过量方面的重要作用。这一监管变化为将这些试纸带给全国各地的零售商提供了一个好时机,将其定位在不断扩大的医学检测类别中。随着越来越多的消费者和医疗保健提供者寻求有效的方法来检测危险物质,Safety Strips准备通过旨在挽救生命的创新、高灵敏度产品来满足这一关键需求。

About Safety Strips Tech Corp.

关于安全条带科技公司

Safety Strips Tech Corp. is an innovative leader in the development and distribution of test strips designed to detect toxic substances in various environments. Utilizing advanced AI-powered technology, Safety Strips provides reliable, easy-to-use testing solutions aimed at reducing harm and improving public health. The company is dedicated to expanding its product portfolio into wellness and health sectors, offering consumers a comprehensive approach to safety and well-being.

Safety Strips Tech Corp. 是开发和分销旨在检测各种环境中有毒物质的试纸的创新领导者。Safety Strips采用先进的人工智能技术,提供可靠、易于使用的测试解决方案,旨在减少伤害和改善公共健康。该公司致力于将其产品组合扩展到健康和健康领域,为消费者提供全面的安全和福祉方法。

About Safe Supply Streaming Corp.

关于安全供应流媒体公司

Safe Supply Streaming Corp. (CSE: SPLY) is a publicly traded company specializing in the acquisition, investment, and development of companies within the medical and wellness sectors. With a focus on innovative technology-driven solutions, Safe Supply aims to create sustainable value for its investors while addressing critical needs in the healthcare industry. As the company pivots towards a new strategic direction, it remains committed to delivering high- impact solutions and fostering growth through its diverse portfolio of cutting-edge companies.

Safe Supply Streaming Corp.(CSE:SPLY)是一家上市公司,专门从事医疗和保健领域公司的收购、投资和发展。Safe Supply专注于以创新技术为导向的解决方案,旨在为其投资者创造可持续的价值,同时满足医疗保健行业的关键需求。随着公司朝着新的战略方向发展,它仍然致力于提供高影响力的解决方案,并通过其多元化的尖端公司投资组合促进增长。

This partnership with Greenlane is a significant step forward in our journey, reflecting our commitment to innovation and value creation. As we continue to evolve, we invite retail investors to join us in capitalizing on the immense opportunities ahead.

与 Greenlane 的合作是我们旅程中向前迈出的重要一步,反映了我们对创新和价值创造的承诺。随着我们的不断发展,我们邀请散户投资者加入我们的行列,把握未来的巨大机遇。

For further information, please contact:

欲了解更多信息,请联系:

Investor Relations Contact:

投资者关系联系人:

Safe Supply Streaming Corp.
Email: info@safesupply.com

安全供应流媒体公司
电子邮件:info@safesupply.com

Bill Panagiotakopoulos
Chief Executive Officer and Director
Email: bill@safesupply.com
Website:

比尔·帕纳吉奥塔科普洛斯
首席执行官兼董事
电子邮件:bill@safesupply.com
网站:

Forward-Looking Statements

前瞻性陈述

Certain statements in this press release are forward-looking within the meaning of applicable securities laws. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such statements. Safe Supply Streaming Corp. undertakes no obligation to update forward-looking statements, except as required by law.

根据适用的证券法,本新闻稿中的某些陈述是前瞻性的。这些前瞻性陈述涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致实际结果或事件与此类陈述中的预期存在重大差异。除非法律要求,否则Safe Supply Streaming Corp. 没有义务更新前瞻性陈述。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发